Bharathiraja SubramaniyanEmily C. FalconAndrew R. MooreJason L. LarabeeSusan L. NimmoJorge L. Berrios-RiveraWilliam J. ReddigEarl L. BlewettJames F. PapinMatthew S. WaltersAnthony W. G. Burgett
sars-cov-2infectious diseasesvirologyoxysterolcovid-19virus researchantiviral drugsimmunologyantiviral researchmedicinal researchimmune responsesantiviral responsesantiviral therapyoxysterol-binding proteintherapeutic targetsantiviral drug development
Reagan M. MogireJohn Muthii MuriukiRuth Fiona BayimenyeAlexander J MentzerAmanda ChongMateus H GouveiaAmy R. BentleyGavin BandPauline KingoriRuth MitchellEmily L WebbDhriti SenguptaLynette EkunweFrancis M NdunguAlireza MorovatAlex W MachariaClare L. CutlandGibran HemaniSodiomon B SirimaMichele RamsayCamila A. FigueiredoAndrew M. PrenticeShabir A MadhiLaura M. RaffieldManjinder S. SandhuPhilip BejonGeorge Davey SmithAlison M ElliottThomas N WilliamsCharles RotimiChristina R. BourneAnthony BurgettAdebowale AdeyemoSarah H Atkinson
geneticsafrican-specific locuspublic healthcardiometabolic health
Zachary C. SeveranceJuan I. NuñezAnh T. Le-McClainCori A. MalinkyRyan C. BensenRobert S. FogleGianni W. ManginelliSophia H. SakersEmily C. FalconRichard Hoang BuiKevin J. SneadChristina R. BourneAnthony W. G. Burgett
medicinal chemistrypharmacologystructural biologystructure-activity relationshipsoxysterol-binding protein